In December 2017 the Canadian Leadership Council on Drug Plan Partnerships met to discuss how Private and Pharmacare can partner to share in the risks of a National Drug Program.

Included in this meeting were our own Paul Crossdale, President MC&A and Kathleen O’Keefe, President Crillion Benefits Advisory Group Inc.  Find out what they had to say.

View the full article here